The approval covers transvaginal gynecologic procedures across Europe.
Intuitive Surgical received the world's first CE mark for transvaginal gynecologic procedures using its da Vinci SP system on 15 September 2026. The regulatory decision expands the platform's labeled indications in Europe to cover transvaginal access for gynecologic operations.
The approval positions Intuitive Surgical as an early mover in single-port, natural-orifice gynecologic surgeries throughout the European region. The company manufactures and markets robotic platforms intended to give surgeons precise control during minimally invasive hospital operations in the United States and internationally.
The expanded clearance allows the medical device maker to widen the procedural scope of its existing da Vinci SP installed base. Investors will monitor European hospital adoption rates and procedure counts tied to the platform in quarterly earnings disclosures through 2027.
Newsletter
Markets in your inbox, weekly
LATAM-focused analysis, investing ideas, and the week in finance.
Keep reading